We are live on ! Find out more
AEMD icon

Aethlon Medical

15 hedge funds and large institutions have $218K invested in Aethlon Medical in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

41% more capital invested

Capital invested by funds: $155K → $218K (+$63.1K)

36% more funds holding

Funds holding: 1115 (+4)

8.23% more ownership

Funds ownership: 2.99%11.21% (+8.2%)

Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
4
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q2 2026 in Review

15 of the 8,343 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2026, worth a combined $218K — up 41% from $155K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new AEMD positions and 2 closed out — a net gain of 4 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $151K. The largest seller was Geode Capital Management, cutting an estimated $29.4K.

  • 15 institutional investors held Aethlon Medical (AEMD) as of Q2 2026, up from 11 in Q1 2026.
  • Funds reported $218K of Aethlon Medical stock for Q2 2026, up 41% quarter-over-quarter.
  • 6 funds opened new Aethlon Medical positions in Q2 2026 and 2 closed out, a net change of +4 holders.
  • The largest Aethlon Medical buyer in Q2 2026 was HRT Financial, an estimated $151K added.
  • The largest Aethlon Medical seller in Q2 2026 was Geode Capital Management, an estimated $29.4K sold.

Based on aggregated 13F filings for Q2 2026.